Your institution may have access to this item. Find your institution then sign in to continue.
Title
The use of GTX as second-line and later chemotherapy for metastatic pancreatic cancer: a retrospective analysis.
Authors
Dakik, Hassan K; Moskovic, Daniel J; Carlson, Peter J; Tamm, Eric P; Qiao, Wei; Wolff, Robert A; Abbruzzese, James L; Fogelman, David R
Abstract
There are limited data regarding the role of second-line treatment for metastatic pancreatic cancer (mPC) after the failure of initial chemotherapy. No data exist on the use of GTX after the failure of first-line therapy.
Publication
Cancer chemotherapy and pharmacology, 2012, Vol 69, Issue 2, p425